<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-204 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-204</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-204</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-8.html">extraction-schema-8</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific brain cell types reported as most susceptible or most resilient in Alzheimer's disease, along with where and when this was observed, how it was measured, quantitative results, proposed mechanisms (including genetic risk enrichment), modifiers (e.g., sex, APOE), contradictions, and any causal/perturbational evidence.</div>
                <p><strong>Paper ID:</strong> paper-44e357e07075bb97350c60a65915386e8bcaa6a2</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/44e357e07075bb97350c60a65915386e8bcaa6a2" target="_blank">Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons</a></p>
                <p><strong>Paper Venue:</strong> Proceedings of the National Academy of Sciences of the United States of America</p>
                <p><strong>Paper TL;DR:</strong> Molecular evaluation of cells from metabolically affected brain regions could provide new information about the pathogenesis of AD and new targets at which to aim disease-slowing and prevention therapies.</p>
                <p><strong>Cost:</strong> 0.021</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e204.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e204.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific brain cell types reported as most susceptible or most resilient in Alzheimer's disease, along with where and when this was observed, how it was measured, quantitative results, proposed mechanisms (including genetic risk enrichment), modifiers (e.g., sex, APOE), contradictions, and any causal/perturbational evidence.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PCC pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Posterior cingulate cortex layer III pyramidal neuron (non-tangle-bearing)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Layer III pyramidal neurons microdissected from human posterior cingulate cortex show the largest regional underexpression of nuclear-encoded mitochondrial electron transport chain (ETC) and translocase genes in late-onset AD, with corresponding decreases in multiple ETC protein subunits.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_name</strong></td>
                            <td>PCC pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_subtype_or_state</strong></td>
                            <td>non-tangle-bearing (thioflavin-S negative) layer III pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_class</strong></td>
                            <td>excitatory neuron (pyramidal)</td>
                        </tr>
                        <tr>
                            <td><strong>markers_or_genes</strong></td>
                            <td>Selection/exclusion markers: thioflavin-S (to exclude tangle-bearing cells), GFAP expression used to exclude astrocyte-contaminated samples; measured molecular markers: nuclear-encoded ETC genes (e.g., NDUFA*, NDUFB*, NDUFS*, NDUFV*, SDHA/B/C/D, UQCRC1/2, UQCRFS1, CYC1, COX4I1/5A/5B/6A1/6B1/6C/7A2L/7B/7C/8A, ATP5A1/B/C1/D/E/F1/G1-3/H/I/J/J2/L/O) and mitochondrial translocases (TIMMs/TOMMs); proteins validated: ND6 (complex I subunit), complex II 30-kDa subunit, complex III core 2, COXII (complex IV), ATP synthase F1α (complex V).</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region_and_layer</strong></td>
                            <td>Posterior cingulate cortex (Brodmann areas 23/31), cortical layer III (pyramidal neurons)</td>
                        </tr>
                        <tr>
                            <td><strong>species_or_model</strong></td>
                            <td>Human postmortem late-onset Alzheimer's disease</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage_or_braak</strong></td>
                            <td>Late-stage AD donors (Braak stage V–VI; CERAD moderate or frequent)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_label</strong></td>
                            <td>susceptible</td>
                        </tr>
                        <tr>
                            <td><strong>measurement_type</strong></td>
                            <td>Laser-capture microdissection of neurons followed by Affymetrix U133 Plus 2.0 microarray transcriptomics; western blot protein validation on PCC whole-tissue extracts</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_change</strong></td>
                            <td>Transcriptomics: 70% of the 80 nuclear ETC/translocase genes significantly underexpressed in PCC neurons (P < 0.01, multiple-testing corrected). Table 1 shows many subunits with median fold reductions by complex (e.g., Complex I: 28/39 subunits underexpressed, fold ≈ -3.0 reported in table); Western blot (PCC whole-brain extract): complex I (ND6) = 41.9% ± 7.0% of control (P < 0.006), complex II = 70.6% ± 9.5% of control (P < 0.000005), complex III = 45.3% ± 7.8% (P < 0.008), complex IV (COXII) = 59.1% ± 9.3% (P < 0.002), complex V = 72.4% ± 11.1% (P < 0.000008).</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_measured</strong></td>
                            <td>Neuronal nuclear gene expression for mitochondrial ETC and mitochondrial translocases; protein levels of representative ETC subunits; neurons selected to be non-tangle bearing (thioflavin-S negative).</td>
                        </tr>
                        <tr>
                            <td><strong>associations_with_pathology</strong></td>
                            <td>No direct statistical correlations to plaque/tangle burden reported for these neurons in this dataset; authors relate regional neuronal ETC underexpression to previously reported regional FDG-PET hypometabolism in PCC and to APOE ε4-related early hypometabolism from prior studies (discussed qualitatively, no r/p-values provided here).</td>
                        </tr>
                        <tr>
                            <td><strong>spatial_or_proximity_context</strong></td>
                            <td>Region-specific (PCC) and laminar specificity (layer III pyramidal somata); neurons were non-tangle-bearing (explicitly excluded tangle-containing cells by thioflavin-S).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_hypothesis</strong></td>
                            <td>Reduced neuronal expression of nuclear-encoded ETC subunits and of TIMM/TOMM translocases → impaired assembly/import of ETC components → mitochondrial dysfunction and reduced neuronal energy metabolism, which may underlie FDG-PET hypometabolism in PCC and potentially precede amyloid/tangle pathology.</td>
                        </tr>
                        <tr>
                            <td><strong>ad_gwas_gene_enrichment</strong></td>
                            <td>No AD GWAS risk-gene enrichment analysis reported for these cell-type findings; APOE discussed in introduction as relevant to PCC hypometabolism but no enrichment or stratified analysis presented.</td>
                        </tr>
                        <tr>
                            <td><strong>perturbation_or_causal_evidence</strong></td>
                            <td>None provided — authors explicitly state the descriptive nature of the study prevents causal inference and no genetic or pharmacologic perturbations were performed on these human neurons.</td>
                        </tr>
                        <tr>
                            <td><strong>modifiers_and_risk_factors</strong></td>
                            <td>APOE ε4 discussed in background as associated with early PCC hypometabolism (from prior PET studies), but APOE genotype was not analyzed as a modifier in these transcriptomic data; sex and age were controlled/matched but no interactions reported.</td>
                        </tr>
                        <tr>
                            <td><strong>comorbid_pathologies</strong></td>
                            <td>Donors had AD neuropathology (Braak V–VI, CERAD moderate/frequent); neurons used were non-tangle-bearing; other co-pathologies (e.g., TDP-43, Lewy bodies, vascular pathology) not reported as influencing these specific neuron-level results in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>comparisons_to_other_cell_types</strong></td>
                            <td>Study focused on neurons only (laser-capture microdissected neuronal soma); authors contrast neuronal findings to prior suggestions that perisynaptic glia may influence PET signals but did not measure glial transcription here.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_or_null_findings</strong></td>
                            <td>Authors note that many genes beyond metabolism genes are underexpressed in AD across regions (i.e., a generalized pattern) and explicitly acknowledge they did not assess mitochondrially encoded genes or glial cells; prior work cited shows some regional differences (e.g., motor cortex relatively spared in earlier reports).</td>
                        </tr>
                        <tr>
                            <td><strong>replication_or_cross_cohort_validation</strong></td>
                            <td>Protein-level Western blot validation performed on PCC tissue (n = 10 AD, n = 5 controls) confirming lower protein levels of tested ETC subunits; authors cite prior reports (refs 38, 39, 40) that provide confirmatory evidence in other cortical regions or activity assays.</td>
                        </tr>
                        <tr>
                            <td><strong>sample_size_and_counts</strong></td>
                            <td>AD donors: 33 (15 males, 18 females) late-onset AD cases used for tissue collection; for each individual ~500 histopathologically normal pyramidal neurons were laser-capture microdissected per region; Western blot validation: n = 10 AD and n = 5 normal controls for PCC protein measurements. (Control donor count for arrays referenced to previous study but not enumerated in-text here.)</td>
                        </tr>
                        <tr>
                            <td><strong>dataset_or_platform</strong></td>
                            <td>Laser-capture microdissection (Arcturus Veritas) + Affymetrix Human Genome U133 Plus 2.0 arrays; data deposited in GEO (GSE5281 for control samples); Western blotting with Mitosciences OXPHOS antibody mixture.</td>
                        </tr>
                        <tr>
                            <td><strong>functional_impact</strong></td>
                            <td>Authors propose that reduced neuronal ETC gene/protein expression may underlie regional FDG-PET hypometabolism, impair neuronal energy metabolism, and contribute to early AD pathogenesis and cognitive network dysfunction (e.g., default-mode network), suggesting potential metabolic-targeted therapeutic strategies.</td>
                        </tr>
                        <tr>
                            <td><strong>key_evidence_snippet</strong></td>
                            <td>“Compared with controls, AD cases had significantly lower expression of 70% of the nuclear genes encoding mitochondrial electron transport chain subunits in posterior cingulate cortex pyramidal neurons… Western blots confirmed underexpression of those complex I–V subunits assessed at the protein level.”</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons", 'publication_date_yy_mm': '2008-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e204.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e204.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific brain cell types reported as most susceptible or most resilient in Alzheimer's disease, along with where and when this was observed, how it was measured, quantitative results, proposed mechanisms (including genetic risk enrichment), modifiers (e.g., sex, APOE), contradictions, and any causal/perturbational evidence.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>MTG pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Middle temporal gyrus layer III pyramidal neuron (non-tangle-bearing)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Layer III pyramidal neurons from middle temporal gyrus (MTG) show substantial underexpression of nuclear-encoded mitochondrial ETC genes in AD, second to PCC in magnitude across sampled regions.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_name</strong></td>
                            <td>MTG pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_subtype_or_state</strong></td>
                            <td>non-tangle-bearing layer III pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_class</strong></td>
                            <td>excitatory neuron (pyramidal)</td>
                        </tr>
                        <tr>
                            <td><strong>markers_or_genes</strong></td>
                            <td>Measured nuclear-encoded ETC genes and TIMM/TOMM translocases (same gene set as PCC analysis); thioflavin-S used to exclude tangle-bearing neurons; GFAP used for neuronal-purity QC.</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region_and_layer</strong></td>
                            <td>Middle temporal gyrus (Brodmann areas 21/37), cortical layer III pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>species_or_model</strong></td>
                            <td>Human postmortem late-onset Alzheimer's disease</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage_or_braak</strong></td>
                            <td>Late-stage AD donors (Braak V–VI; CERAD moderate/frequent)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_label</strong></td>
                            <td>susceptible (regionally vulnerable, slightly less than PCC)</td>
                        </tr>
                        <tr>
                            <td><strong>measurement_type</strong></td>
                            <td>LCM + Affymetrix microarray transcriptomics (region-specific neuron samples)</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_change</strong></td>
                            <td>65% of the nuclear ETC/translocase genes significantly underexpressed in MTG neurons (P < 0.01, corrected). Table 1 reports e.g., Complex I: 27/39 (69%) subunits underexpressed with fold ≈ -2.5; other complexes likewise show multiple subunits underexpressed (see Table 1).</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_measured</strong></td>
                            <td>Neuronal nuclear ETC/translocase gene expression (transcript-level) in non-tangle-bearing pyramidal neurons.</td>
                        </tr>
                        <tr>
                            <td><strong>associations_with_pathology</strong></td>
                            <td>Associations are qualitative: MTG underexpression is consistent with PET-detected hypometabolism in temporal cortex in AD (cited), but no within-study correlation statistics presented.</td>
                        </tr>
                        <tr>
                            <td><strong>spatial_or_proximity_context</strong></td>
                            <td>Regional (MTG) and laminar (layer III pyramidal soma) specificity.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_hypothesis</strong></td>
                            <td>Same mitochondrial/ETC underexpression mechanism hypothesized to reduce neuronal energy metabolism contributing to regional hypometabolism and vulnerability.</td>
                        </tr>
                        <tr>
                            <td><strong>ad_gwas_gene_enrichment</strong></td>
                            <td>Not assessed in this study for MTG neurons.</td>
                        </tr>
                        <tr>
                            <td><strong>perturbation_or_causal_evidence</strong></td>
                            <td>None provided.</td>
                        </tr>
                        <tr>
                            <td><strong>modifiers_and_risk_factors</strong></td>
                            <td>APOE and other modifiers discussed in background but not analyzed for MTG-specific data.</td>
                        </tr>
                        <tr>
                            <td><strong>comorbid_pathologies</strong></td>
                            <td>Not reported to affect interpretation for MTG neuronal data in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>comparisons_to_other_cell_types</strong></td>
                            <td>Compared across cortical regions (PCC > MTG > HIP > EC > VC > SFG) rather than to non-neuronal cell classes.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_or_null_findings</strong></td>
                            <td>No direct contradictions within this paper; prior studies cited show regional variability (e.g., motor cortex spared in earlier reports).</td>
                        </tr>
                        <tr>
                            <td><strong>replication_or_cross_cohort_validation</strong></td>
                            <td>Consistent with earlier reports of ETC underexpression in middle temporal cortex cited in refs 38, 39.</td>
                        </tr>
                        <tr>
                            <td><strong>sample_size_and_counts</strong></td>
                            <td>Same donor cohort as main study (AD donors n = 33); ~500 neurons per region collected per individual; present-call and QC filtering applied to arrays (some arrays/samples removed).</td>
                        </tr>
                        <tr>
                            <td><strong>dataset_or_platform</strong></td>
                            <td>Affymetrix Human Genome U133 Plus 2.0 arrays on LCM-isolated neurons.</td>
                        </tr>
                        <tr>
                            <td><strong>functional_impact</strong></td>
                            <td>Implicated in regional energy hypometabolism observed by FDG-PET in AD; may contribute to functional decline in temporal association cortex.</td>
                        </tr>
                        <tr>
                            <td><strong>key_evidence_snippet</strong></td>
                            <td>“AD cases had significantly lower expression of 65% of the nuclear genes encoding mitochondrial electron transport chain subunits in middle temporal gyrus neurons…”</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons", 'publication_date_yy_mm': '2008-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e204.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e204.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific brain cell types reported as most susceptible or most resilient in Alzheimer's disease, along with where and when this was observed, how it was measured, quantitative results, proposed mechanisms (including genetic risk enrichment), modifiers (e.g., sex, APOE), contradictions, and any causal/perturbational evidence.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>CA1 pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Hippocampal CA1 pyramidal neuron (non-tangle-bearing)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>CA1 pyramidal neurons microdissected from hippocampus show a high proportion of underexpressed nuclear-encoded ETC genes in AD, indicating substantial metabolic involvement in hippocampal neurons.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_name</strong></td>
                            <td>CA1 pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_subtype_or_state</strong></td>
                            <td>non-tangle-bearing (thioflavin-S negative) CA1 pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_class</strong></td>
                            <td>excitatory neuron (pyramidal)</td>
                        </tr>
                        <tr>
                            <td><strong>markers_or_genes</strong></td>
                            <td>Same set of nuclear-encoded ETC and TIMM/TOMM genes measured; thioflavin-S used to exclude tangle-bearing cells in sampling.</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region_and_layer</strong></td>
                            <td>Hippocampus CA1 field (somatic layer), pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>species_or_model</strong></td>
                            <td>Human postmortem late-onset Alzheimer's disease</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage_or_braak</strong></td>
                            <td>Late-stage AD donors (Braak V–VI; CERAD moderate/frequent)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_label</strong></td>
                            <td>susceptible</td>
                        </tr>
                        <tr>
                            <td><strong>measurement_type</strong></td>
                            <td>LCM of CA1 pyramidal neurons followed by Affymetrix microarray transcriptomics</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_change</strong></td>
                            <td>61% of the nuclear ETC/translocase genes significantly underexpressed in HIP neurons (P < 0.01, corrected). Table 1 reports e.g., Complex I: 25/39 (64%) subunits underexpressed with fold ≈ -2.5; Complex V: 10/15 (67%) underexpressed (fold ≈ -2.7).</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_measured</strong></td>
                            <td>Neuronal nuclear gene expression; neurons sampled were histopathologically normal-appearing (no thioflavin-S positive tangles).</td>
                        </tr>
                        <tr>
                            <td><strong>associations_with_pathology</strong></td>
                            <td>No direct within-study statistical associations to tangle burden reported here; hippocampus CA1 is noted as an area metabolically affected in AD per PET and tangle-prone in neuropathology literature.</td>
                        </tr>
                        <tr>
                            <td><strong>spatial_or_proximity_context</strong></td>
                            <td>Region-specific (hippocampal CA1) sampling of non-tangle-bearing neuronal somata.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_hypothesis</strong></td>
                            <td>Underexpression of ETC/translocase genes may impair mitochondrial function in CA1 neurons, contributing to hippocampal hypometabolism and dysfunction in AD.</td>
                        </tr>
                        <tr>
                            <td><strong>ad_gwas_gene_enrichment</strong></td>
                            <td>Not analyzed.</td>
                        </tr>
                        <tr>
                            <td><strong>perturbation_or_causal_evidence</strong></td>
                            <td>None provided.</td>
                        </tr>
                        <tr>
                            <td><strong>modifiers_and_risk_factors</strong></td>
                            <td>No CA1-specific modifier analyses presented.</td>
                        </tr>
                        <tr>
                            <td><strong>comorbid_pathologies</strong></td>
                            <td>CA1 is known to be tangle-prone historically, but sampled neurons were non-tangle-bearing; additional comorbid pathologies not reported as influencing these findings here.</td>
                        </tr>
                        <tr>
                            <td><strong>comparisons_to_other_cell_types</strong></td>
                            <td>Compared across cortical/hippocampal regions (HIP among most affected regions after PCC and MTG).</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_or_null_findings</strong></td>
                            <td>The paper notes broader underexpression across many gene classes in AD, indicating the mitochondrial findings are part of a larger pattern; authors also acknowledge they did not assay mitochondrial-genome-encoded transcripts.</td>
                        </tr>
                        <tr>
                            <td><strong>replication_or_cross_cohort_validation</strong></td>
                            <td>Findings for hippocampus align with prior PET and some expression studies cited; no independent cohort validation within this paper beyond cross-region comparisons and PCC western blot.</td>
                        </tr>
                        <tr>
                            <td><strong>sample_size_and_counts</strong></td>
                            <td>Same donor cohort (AD n = 33); ~500 CA1 neurons collected per individual; array QC described (some arrays excluded).</td>
                        </tr>
                        <tr>
                            <td><strong>dataset_or_platform</strong></td>
                            <td>LCM + Affymetrix Human Genome U133 Plus 2.0 arrays.</td>
                        </tr>
                        <tr>
                            <td><strong>functional_impact</strong></td>
                            <td>Implicated in reduced hippocampal energy metabolism which may underlie memory-related dysfunction in AD.</td>
                        </tr>
                        <tr>
                            <td><strong>key_evidence_snippet</strong></td>
                            <td>“AD cases had significantly lower expression of 61% of the nuclear genes encoding mitochondrial electron transport chain subunits in hippocampal CA1 neurons…”</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons", 'publication_date_yy_mm': '2008-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e204.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e204.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific brain cell types reported as most susceptible or most resilient in Alzheimer's disease, along with where and when this was observed, how it was measured, quantitative results, proposed mechanisms (including genetic risk enrichment), modifiers (e.g., sex, APOE), contradictions, and any causal/perturbational evidence.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EC layer II stellate neuron</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Entorhinal cortex layer II large stellate neuron (non-tangle-bearing)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Large layer II stellate neurons from entorhinal cortex (EC) show more modest underexpression of nuclear-encoded ETC/translocase genes in AD compared with PCC/MTG/HIP, indicating relatively less metabolic gene downregulation in this cell population in this dataset.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_name</strong></td>
                            <td>Entorhinal cortex layer II stellate neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_subtype_or_state</strong></td>
                            <td>non-tangle-bearing large stellate neurons (layer II)</td>
                        </tr>
                        <tr>
                            <td><strong>cell_class</strong></td>
                            <td>excitatory neuron (stellate/principal cell of EC layer II)</td>
                        </tr>
                        <tr>
                            <td><strong>markers_or_genes</strong></td>
                            <td>Thioflavin-S negative selection to exclude tangle-bearing cells; measured nuclear ETC and TIMM/TOMM genes as above.</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region_and_layer</strong></td>
                            <td>Entorhinal cortex (Brodmann areas 28 and 34), layer II stellate neurons</td>
                        </tr>
                        <tr>
                            <td><strong>species_or_model</strong></td>
                            <td>Human postmortem late-onset Alzheimer's disease</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage_or_braak</strong></td>
                            <td>Late-stage AD donors (Braak V–VI; CERAD moderate/frequent)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_label</strong></td>
                            <td>mixed/region-specific (intermediate vulnerability; less underexpression than PCC/MTG/HIP)</td>
                        </tr>
                        <tr>
                            <td><strong>measurement_type</strong></td>
                            <td>LCM + Affymetrix microarray transcriptomics on EC layer II stellate neurons</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_change</strong></td>
                            <td>23% of nuclear ETC/translocase genes significantly underexpressed in EC layer II stellate neurons (P < 0.01, corrected). Table 1 indicates smaller numbers of subunits per complex reach significance (e.g., Complex I: 9/39 (23%), reported fold median ≈ -4.5 for those subunits).</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_measured</strong></td>
                            <td>Neuronal nuclear gene expression (ETC/translocase genes); neurons were selected to be thioflavin-S negative.</td>
                        </tr>
                        <tr>
                            <td><strong>associations_with_pathology</strong></td>
                            <td>No direct correlations presented; EC is noted in literature as tangle-prone early but sampled neurons here were non-tangle-bearing, and EC showed fewer ETC changes relative to PCC/MTG/HIP.</td>
                        </tr>
                        <tr>
                            <td><strong>spatial_or_proximity_context</strong></td>
                            <td>Layer II-specific sampling (stellate neurons) in EC; laminar consideration emphasized.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_hypothesis</strong></td>
                            <td>Authors imply regional variation in mitochondrial gene underexpression may reflect differential vulnerability tied to region-specific metabolic demands or pathologic cascades; EC stellate neurons show less neuronal nuclear ETC underexpression in this dataset.</td>
                        </tr>
                        <tr>
                            <td><strong>ad_gwas_gene_enrichment</strong></td>
                            <td>Not assessed.</td>
                        </tr>
                        <tr>
                            <td><strong>perturbation_or_causal_evidence</strong></td>
                            <td>None provided.</td>
                        </tr>
                        <tr>
                            <td><strong>modifiers_and_risk_factors</strong></td>
                            <td>Not analyzed specifically for EC samples in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>comorbid_pathologies</strong></td>
                            <td>EC layer II is historically tangle-prone, but neurons sampled were non-tangle-bearing; no additional comorbid pathologies analyzed here.</td>
                        </tr>
                        <tr>
                            <td><strong>comparisons_to_other_cell_types</strong></td>
                            <td>Direct regional comparison shows EC neurons have markedly fewer underexpressed ETC genes than PCC, MTG, and HIP neurons.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_or_null_findings</strong></td>
                            <td>Authors note that while EC is tangle-prone, in this dataset EC neurons showed fewer ETC changes, highlighting possible dissociation between tangle presence and neuronal nuclear ETC underexpression.</td>
                        </tr>
                        <tr>
                            <td><strong>replication_or_cross_cohort_validation</strong></td>
                            <td>No separate validation cohort for EC-specific findings reported; results compared across regions within same cohort.</td>
                        </tr>
                        <tr>
                            <td><strong>sample_size_and_counts</strong></td>
                            <td>Same donor cohort (AD n = 33); ~500 EC layer II stellate neurons collected per individual; nine previously collected EC samples reanalyzed on arrays as noted.</td>
                        </tr>
                        <tr>
                            <td><strong>dataset_or_platform</strong></td>
                            <td>LCM + Affymetrix Human Genome U133 Plus 2.0 arrays.</td>
                        </tr>
                        <tr>
                            <td><strong>functional_impact</strong></td>
                            <td>Relatively smaller transcriptional downregulation of mitochondrial genes in EC layer II stellate neurons suggests these neurons may have different metabolic perturbation profiles compared with PCC/MTG/HIP neurons, with implications for region-specific vulnerability in AD.</td>
                        </tr>
                        <tr>
                            <td><strong>key_evidence_snippet</strong></td>
                            <td>“AD cases had significantly lower expression of 23% of the nuclear genes encoding mitochondrial electron transport chain subunits in entorhinal cortex layer II stellate neurons…”</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons", 'publication_date_yy_mm': '2008-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e204.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e204.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific brain cell types reported as most susceptible or most resilient in Alzheimer's disease, along with where and when this was observed, how it was measured, quantitative results, proposed mechanisms (including genetic risk enrichment), modifiers (e.g., sex, APOE), contradictions, and any causal/perturbational evidence.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>VC pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Primary visual cortex (V1) layer III pyramidal neuron (non-tangle-bearing)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Layer III pyramidal neurons from primary visual cortex, a region relatively spared in AD PET studies, show comparatively little underexpression of nuclear-encoded ETC genes in AD in this dataset.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_name</strong></td>
                            <td>Visual cortex (V1) pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_subtype_or_state</strong></td>
                            <td>non-tangle-bearing layer III pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_class</strong></td>
                            <td>excitatory neuron (pyramidal)</td>
                        </tr>
                        <tr>
                            <td><strong>markers_or_genes</strong></td>
                            <td>ETC and TIMM/TOMM gene panels measured; thioflavin-S negative selection; GFAP used for QC.</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region_and_layer</strong></td>
                            <td>Primary visual cortex (Brodmann area 17), cortical layer III pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>species_or_model</strong></td>
                            <td>Human postmortem late-onset Alzheimer's disease</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage_or_braak</strong></td>
                            <td>Late-stage AD donors (Braak V–VI; CERAD moderate/frequent)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_label</strong></td>
                            <td>resilient (relatively spared)</td>
                        </tr>
                        <tr>
                            <td><strong>measurement_type</strong></td>
                            <td>LCM + Affymetrix microarray transcriptomics</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_change</strong></td>
                            <td>16% of the nuclear ETC/translocase genes significantly underexpressed in VC neurons (P < 0.01, corrected). Table 1 shows e.g., Complex I: 7/39 (18%) subunits underexpressed, with fold ≈ -1.8 for those affected.</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_measured</strong></td>
                            <td>Neuronal nuclear ETC/translocase gene expression in non-tangle-bearing VC pyramidal neurons.</td>
                        </tr>
                        <tr>
                            <td><strong>associations_with_pathology</strong></td>
                            <td>VC is noted as relatively spared in FDG-PET and this transcriptional pattern mirrors that regional resilience; no direct within-study statistical association metrics provided.</td>
                        </tr>
                        <tr>
                            <td><strong>spatial_or_proximity_context</strong></td>
                            <td>Regional (V1) and laminar (layer III) specificity; VC designated as relatively spared region.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_hypothesis</strong></td>
                            <td>Lower magnitude of mitochondrial gene underexpression may reflect lower metabolic vulnerability or different pathophysiologic timecourse in VC compared with association cortices.</td>
                        </tr>
                        <tr>
                            <td><strong>ad_gwas_gene_enrichment</strong></td>
                            <td>Not assessed.</td>
                        </tr>
                        <tr>
                            <td><strong>perturbation_or_causal_evidence</strong></td>
                            <td>None provided.</td>
                        </tr>
                        <tr>
                            <td><strong>modifiers_and_risk_factors</strong></td>
                            <td>Not specifically analyzed for VC in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>comorbid_pathologies</strong></td>
                            <td>Not reported to alter VC neuron findings here.</td>
                        </tr>
                        <tr>
                            <td><strong>comparisons_to_other_cell_types</strong></td>
                            <td>Directly compared across regions—VC shows far fewer underexpressed ETC genes than PCC/MTG/HIP.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_or_null_findings</strong></td>
                            <td>None reported within this paper; authors note overall many genes are underexpressed in AD, but VC displays relatively limited changes in ETC genes.</td>
                        </tr>
                        <tr>
                            <td><strong>replication_or_cross_cohort_validation</strong></td>
                            <td>Pattern is consistent with PET literature showing relative sparing of primary visual cortex in AD; no independent transcriptomic cohort validation provided here.</td>
                        </tr>
                        <tr>
                            <td><strong>sample_size_and_counts</strong></td>
                            <td>Same donor cohort (AD n = 33); ~500 VC pyramidal neurons collected per individual; array and present-call QC applied.</td>
                        </tr>
                        <tr>
                            <td><strong>dataset_or_platform</strong></td>
                            <td>LCM + Affymetrix U133 Plus 2.0 microarrays.</td>
                        </tr>
                        <tr>
                            <td><strong>functional_impact</strong></td>
                            <td>Relatively preserved mitochondrial gene expression in VC is consistent with preserved glucose metabolism by PET and suggests region-specific protection of primary sensory cortex in AD.</td>
                        </tr>
                        <tr>
                            <td><strong>key_evidence_snippet</strong></td>
                            <td>“Compared with controls, AD cases had significantly lower expression of 16% of the nuclear genes encoding mitochondrial electron transport chain subunits in visual cortex neurons… the primary visual cortex is relatively spared.”</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons", 'publication_date_yy_mm': '2008-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e204.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e204.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific brain cell types reported as most susceptible or most resilient in Alzheimer's disease, along with where and when this was observed, how it was measured, quantitative results, proposed mechanisms (including genetic risk enrichment), modifiers (e.g., sex, APOE), contradictions, and any causal/perturbational evidence.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>SFG pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Superior frontal gyrus layer III pyramidal neuron (non-tangle-bearing)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Layer III pyramidal neurons microdissected from superior frontal gyrus (SFG), a region more associated with normal aging than early AD, show minimal underexpression of nuclear-encoded ETC genes in AD in this dataset.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_name</strong></td>
                            <td>Superior frontal gyrus pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_subtype_or_state</strong></td>
                            <td>non-tangle-bearing layer III pyramidal neuron</td>
                        </tr>
                        <tr>
                            <td><strong>cell_class</strong></td>
                            <td>excitatory neuron (pyramidal)</td>
                        </tr>
                        <tr>
                            <td><strong>markers_or_genes</strong></td>
                            <td>Measured nuclear-encoded ETC and translocase genes; thioflavin-S negative selection; GFAP QC applied.</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region_and_layer</strong></td>
                            <td>Superior frontal gyrus (Brodmann areas 10/11), cortical layer III pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>species_or_model</strong></td>
                            <td>Human postmortem late-onset Alzheimer's disease</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage_or_braak</strong></td>
                            <td>Late-stage AD donors (Braak V–VI; CERAD moderate/frequent)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_label</strong></td>
                            <td>resilient (relatively spared / least affected among sampled regions)</td>
                        </tr>
                        <tr>
                            <td><strong>measurement_type</strong></td>
                            <td>LCM + Affymetrix microarray transcriptomics</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_change</strong></td>
                            <td>5% (text states 5% in one place; Table 1 reports lower proportions per complex, e.g., Complex I: 4/39 (10%) underexpressed) of nuclear ETC/translocase genes significantly underexpressed in SFG neurons (P < 0.01, corrected); overall SFG exhibited the lowest proportion of underexpressed ETC genes among sampled regions.</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_measured</strong></td>
                            <td>Neuronal nuclear gene expression for ETC and translocases in non-tangle-bearing layer III pyramidal neurons.</td>
                        </tr>
                        <tr>
                            <td><strong>associations_with_pathology</strong></td>
                            <td>SFG is described as preferentially affected by normal aging rather than early AD per cited literature; in this dataset SFG shows minimal mitochondrial gene underexpression, aligning with PET/aging distinctions.</td>
                        </tr>
                        <tr>
                            <td><strong>spatial_or_proximity_context</strong></td>
                            <td>Regional (SFG) and laminar (layer III) sampling; SFG designated as relatively spared with respect to AD-related ETC underexpression in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_hypothesis</strong></td>
                            <td>Authors suggest regional differences in mitochondrial gene expression relate to differential regional vulnerability; SFG shows relative preservation of these nuclear-encoded mitochondrial transcripts in AD.</td>
                        </tr>
                        <tr>
                            <td><strong>ad_gwas_gene_enrichment</strong></td>
                            <td>Not assessed.</td>
                        </tr>
                        <tr>
                            <td><strong>perturbation_or_causal_evidence</strong></td>
                            <td>None provided.</td>
                        </tr>
                        <tr>
                            <td><strong>modifiers_and_risk_factors</strong></td>
                            <td>Not analyzed specifically for SFG in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>comorbid_pathologies</strong></td>
                            <td>Not reported to confound SFG neuron findings in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>comparisons_to_other_cell_types</strong></td>
                            <td>SFG neurons had the smallest proportion of underexpressed ETC genes in direct regional comparisons, indicating relative resilience compared with PCC, MTG, and HIP neurons.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_or_null_findings</strong></td>
                            <td>None within this paper; authors acknowledge broad underexpression across many genes in AD and discuss regional patterns relative to PET findings and aging literature.</td>
                        </tr>
                        <tr>
                            <td><strong>replication_or_cross_cohort_validation</strong></td>
                            <td>Pattern consistent with prior metabolic topography literature cited (refs 29–33) but no independent transcriptomic cohort validation provided here.</td>
                        </tr>
                        <tr>
                            <td><strong>sample_size_and_counts</strong></td>
                            <td>Same donor cohort (AD n = 33); ~500 SFG pyramidal neurons collected per individual; arrays underwent QC filtering.</td>
                        </tr>
                        <tr>
                            <td><strong>dataset_or_platform</strong></td>
                            <td>LCM + Affymetrix Human Genome U133 Plus 2.0 arrays.</td>
                        </tr>
                        <tr>
                            <td><strong>functional_impact</strong></td>
                            <td>Relative preservation of mitochondrial gene expression in SFG suggests lesser contribution of neuronal energy-gene downregulation to SFG dysfunction in AD and supports regional specificity of metabolic impairment.</td>
                        </tr>
                        <tr>
                            <td><strong>key_evidence_snippet</strong></td>
                            <td>“In comparison with controls, AD cases had significantly lower expression of 5% of the nuclear genes encoding mitochondrial ETC subunits in the superior frontal gyrus (and only 16% in visual cortex), whereas 70% were underexpressed in PCC.”</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons", 'publication_date_yy_mm': '2008-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease <em>(Rating: 2)</em></li>
                <li>Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E <em>(Rating: 2)</em></li>
                <li>Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia <em>(Rating: 2)</em></li>
                <li>Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease <em>(Rating: 2)</em></li>
                <li>Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease <em>(Rating: 2)</em></li>
                <li>Cytochrome oxidase histochemistry in human Alzheimer's disease and animal models <em>(Rating: 2)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>